value-based care

Flare Capital's Ian Chiang and Poorwa Godbole highlight the healthcare changes COVID-19 has already spurred and discuss why they're likely to stick around for the long haul.

The company's funding news came alongside a new deal with Humana focused on prior authorizations for musculoskeletal treatments.

Flare Capital Partners Principal Ian Chiang offers practical suggestions for innovators finding themselves in the midst of a transition from fee-for-service to fee-for-value.

David Grauer, senior VP at Health Catalyst, says in addition to providing patients with higher quality at a lower cost, we must get better at identifying payment models that reward physicians in the value-based environment.

Healthbox President Neil Patel says healthcare organizations around the globe need to develop innovation strategies and adopt new technologies to survive in a value-based world.

Dr. Mark Sundrakes, SVP and medical director at Krungthai-AXA Life Insurance PCL, discusses the insurance industry's move from payer to partner and from fee-based to value-based healthcare.

Rob Lieberthal, principal of health economics at Mitre, says among the biggest obstacles to reimbursement are the lack of interoperability and patients not owning their data.

Flare Capital Partners' Ian Chiang describes the key capabilities of a value-based care enablement platform for providers, highlights successful platform examples and offers a framework for entrepreneurs seeking a provider partner.